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Streptococcus thermophilus APC151
Strain Is Suitable for the Manufacture
of Naturally GABA-Enriched
Bioactive Yogurt
Daniel M. Linares1,2*, Tom F. O’Callaghan1,2, Paula M. O’Connor1,2, R. P. Ross2 and
Catherine Stanton1,2
1 Food Biosciences Department, Teagasc Food Research Centre Moorepark, Fermoy, Ireland, 2 APC Microbiome Institute,
University College Cork, Cork, Ireland
Consumer interest in health-promoting food products is a major driving force for the
increasing global demand of functional (probiotic) dairy foods. Yogurt is considered the
ideal medium for delivery of beneficial functional ingredients. Gamma-amino-butyric acid
has potential as a bioactive ingredient in functional foods due to its health-promoting
properties as an anti-stress, anti-hypertensive, and anti-diabetic agent. Here, we report
the use of a novel Streptococcus thermophilus strain, isolated from the digestive tract
of fish, for production of yogurt naturally enriched with 2 mg/ml of gamma-amino-
butyric acid (200 mg in a standard yogurt volume of 100 ml), a dose in the same
range as that provided by some commercially available gamma-amino-butyric acid
supplements. The biotechnological suitability of this strain for industrial production
of yogurt was demonstrated by comparison with the reference yogurt inoculated
with the commercial CH1 starter (Chr. Hansen) widely used in the dairy industry.
Both yogurts showed comparable pH curves [1pH/1t = 0.31−0.33 h−1], viscosity
[0.49 Pa-s], water holding capacity [72–73%], and chemical composition [moisture (87–
88%), protein (5.05–5.65%), fat (0.12–0.15%), sugar (4.8–5.8%), and ash (0.74–1.2%)].
Gamma-amino-butyric acid was not detected in the control yogurt. In conclusion, the
S. thermophilus APC151 strain reported here provides a natural means for fortification
of yogurt with gamma-amino-butyric acid.
Keywords: GABA, Streptococcus thermophilus, bioactive yogurt, starter, biofunctional food
INTRODUCTION
Streptococcus thermophilus is a non-pathogenic and homofermentative facultative anaerobic lactic
acid (LAB) bacterium with a long history of use in the home-made and modern industrial
manufacture of fermented dairy products, especially yogurt (Wu et al., 2014). As a dairy starter,
S. thermophilus can rapidly convert lactose into lactic acid, which causes a rapid reduction in
pH resulting in coagulation of milk proteins (casein). In addition, this bacterium confers many
excellent processing properties to the yogurt, such as flavor, acidity, viscosity, and water holding
capacity (Sun et al., 2011).
Since yogurt contains live cultures, it has been considered an ideal vehicle to deliver probiotic
and biofunctional ingredients to the gut. Beneficial effects can be provided by classic strains
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associated with the technological production of the yogurt
(S. thermophilus and Lactobacillus delbrueckii subsp. bulgaricus),
or by additional strains supplemented in order to provide a
probiotic function (generally Lactobacillus or Bifidobacterium).
In this regard, yogurt bacteria have been shown to have a
favorable impact on digestive health improving lactose digestion
in lactose-intolerant individuals (Rul et al., 2011; Savaiano, 2014),
increasing intestinal regularity and digestion (Fioramonti et al.,
2003), preventing diarrhea (Beniwal et al., 2003; Linares et al.,
2016) and inflammatory bowel disease (Lorea Baroja et al., 2007;
Shadnoush et al., 2013), and stimulating the gut immune system
(Hong et al., 2015; Maldonado-Galdeano et al., 2015).
Discovered in 1950, gamma-aminobutyric acid (GABA) is
the main inhibitory neurotransmitter naturally occurring in the
central nervous system (CNS) and some peripheral tissues (Bravo
et al., 2011). Several important physiological functions of GABA
have been characterized, such as neurotransmission, diuretic
effects, relaxing, and tranquilizer effects (Hayakawa et al., 2004;
Li and Cao, 2010). In fact, some GABAA (a type of GABA
receptors) agonist drugs are important pharmacological agents
used for clinical treatment of anxiety (e.g., benzodiazepines)
(Foster and Kemp, 2006). In addition to this stress management
role, GABA was reported to lower blood pressure in humans with
mild hypertension (Shimada et al., 2009; Pouliot-Mathieu et al.,
2013) and to have a significant anti-diabetic effect (Adeghate
and Ponery, 2002; Wan et al., 2015). Beside this, patients with
Alzheimer’s disease have a decreased level of GABA in their
temporal cortex, occipital cortex and cerebellum (Seidl et al.,
2001). Thus, GABA has been classified as a health-promoting
bioactive component in foods and pharmaceuticals (Li and Cao,
2010). In fact, foods enriched with GABA are defined as FOSHU
(Foods for Specified Health Use) by the Japanese government
(Rizzello et al., 2008). A number of commercial sources sell
formulations of GABA for use as a dietary supplement claiming
to have a calming and tranquilizing effect. One of them, Pharma-
GABATM, a natural form of GABA has been approved by the
FDA as a food ingredient (Food and Drug Administration [FDA],
2008).
Several lactic acid bacteria (LAB) have been reported to
exhibit GABA-producing ability through α-decarboxylation of
glutamate, an enzymatic conversion which is catalyzed by
glutamate decarboxylase (GAD) (Tajabadi et al., 2015). Among
them, most of the GABA-producing strains are lactobacilli
(mainly Lb. brevis, Lb. paracasei, Lb. delbrueckii, Lb. buchneri,
Lb. plantarum, and Lb. helveticus) and Lactococcus lactis (Li and
Cao, 2010; Dhakal et al., 2012; Wu et al., 2015). Alternatively,
Bifidobacterium spp strains were reported to produce GABA,
although they have a low capacity for production (Park et al.,
2005; Barrett et al., 2012). So far, only a few S. thermophilus
strains were reported to produce significant levels of GABA
from glutamate (Yang et al., 2008). However, the suitability of
these strains to produce GABA in fermented milk and yogurt
has not yet been explored. The ability of LAB to biosynthesize
GABA is not present in all strains belonging to one species,
as it is a strain-dependent attribute genetically associated to
the genes gadB and gadC (Tajabadi et al., 2015). In addition,
even among those GAD+ strains belonging to the same species,
the efficiency and yield of GABA production varies markedly
(Dhakal et al., 2012). The capacity to produce GABA in high
yields is rare among conventional S. thermophilus (generally from
dairy origin), thus we screened less explored sources such as the
gastrointestinal tract (GIT) of fish (Labrus mixtus) caught off the
coast of Ireland.
Since S. thermophilus is a commercially relevant starter widely
exploited for the industrial production of yogurt, and GABA has
a potential as bioactive component in foods and pharmaceuticals
(Li and Cao, 2010; Wu and Shah, 2016), in this work, we tested
the biotechnological suitability of the newly isolated strain to
coagulate milk and produce naturally GABA-enriched yogurt.
The quality and physical properties of the obtained GABA-rich
yogurt were compared with those of reference yogurts produced
in parallel under similar conditions using commercial starters
widely used in the dairy industry.
MATERIALS AND METHODS
Bacterial Culture Medium and Conditions
Streptococcus thermophilus strains were grown at 42◦C in
M17 medium (Oxoid, Basingstoke, UK) supplemented with
0.5% lactose (LM17). L. delbrueckii subsp. bulgaricus strains
were anaerobically grown in MRS (Difco, Detroit, MI, USA).
Unless indicated otherwise, the medium was supplemented with
2.25 mg/ml of monosodium glutamate (MSG; Sigma–Aldrich).
When solid medium was required, 2% (w/v) agar (Oxoid,
Hampshire, UK) was added to the corresponding medium.
Isolation of GABA-Producer
S. thermophilus Strain
Streptococcus thermophilus is the universal starter for yogurt
fermentation. In order to isolate GABA-producer strains
technologically suitable to produce yogurt, we carried out a
screening in LM17. Because the capacity to produce GABA
in high yields is rare among S. thermophilus, we screened
less explored sources such as fish intestines. A S. thermophilus
APC151 was isolated from the digestive tract of fish (L. mixtus)
caught off the coast of Ireland. Briefly, the intestine was
aseptically extracted, and content transferred into a sterile
stomacher bag, diluted with sterile maximum recovery diluent
(MRD; Oxoid Ltd., Basingstoke, UK) and homogenized for 3 min
in a Stomacher 400 laboratory blender (Seward Ltd., London,
UK). Further, serial dilutions were carried out in MRD, plated on
LM17 agar plates and incubated anaerobically at 42◦C.
Detection and Quantification of GABA
Production
Extracellular GABA that accumulated in the culture medium or
yogurt was quantified by post-column ninhydrin derivatization
on cation-exchange HPLC as follows. Samples of culture
supernatants or yogurt were deproteinized by mixing
equal volumes of 24% (w/v) trichloroacetic acid (TCA)
and sample, these were allowed to stand for 10 min before
centrifuging at 14400 × g (Microcentaur, MSE, UK) for 10 min.
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Supernatants were transferred to a new tube and diluted with
0.2 M sodium citrate buffer, pH 2.2, to give approximately
250 nmol of each amino acid residue. Samples were then
diluted one in two with the internal standard, norleucine,
yielding a final concentration of 125 nm/ml. GABA was
quantified using a Jeol JLC-500/V amino acid analyser [Jeol
(UK) Ltd., Garden city, Herts, UK] fitted with a Jeol Na+
high performance cation exchange column (Mounier et al.,
2007).
Yogurt Manufacture
The fermentation substrate consisted of 14% (w/v) skim milk
(Kerry ingredients Ltd, Kerry, Ireland). For the elaboration of
both yogurts, milk was previously supplemented with 2.25 mg/ml
MSG. Prior to inoculation, milk was heat treated at 121◦C
for 5 min and then cooled to 42◦C. The thermophilic starter
CH1 (obtained from Chr. Hansen, Denmark) was used as
reference for the production of plain set-style yogurt. The two
strains composing this starter (S. thermophilus CH1 and Lb.
delbrueckii subsp. bulgaricus CH1) were isolated and inoculated
in milk in a 1:1 ratio (106 cells of each). The GABA-enriched
yogurt was manufactured in parallel under identical conditions
as the control yogurt except that strain S. thermophilus CH1
was replaced by the GABA-producing strain S. thermophilus
APC151. Thus, both yogurts differed only in the S. thermophilus
strain. Following inoculation, yogurts were fermented in 100 ml
cups at 42◦C for 48 h, and then the samples were rapidly
cooled to 4◦C and stored at this temperature for up to
3 weeks. GABA content, viable bacteria counts, pH, viscosity,
water holding capacity and chemical compositions of yogurts
were monitored at 1, 2, 3, 4, 5, 6, 7, 14 and 21 days
intervals.
Enumeration of Viable Cells in Yogurt
The enumeration of S. thermophilus and Lb. delbrueckii subsp.
bulgaricus viable cells in yogurt were obtained by spread plating
200 µl of 10-fold serial dilutions on agar plates. For selective
enumeration of S. thermophilus, serial dilutions were plated
onto LM17 and incubated at 42◦C. Selective enumeration of Lb.
delbrueckii subsp. bulgaricus was performed on MRS agar plates
incubated at 42◦C under anaerobic conditions. Lb. bulgaricus
and S. thermophilus were identified by their rough-shaped and
smooth-shaped colonies, respectively. After incubation for 48 h,
visible colonies were counted and expressed as colony forming
units per milliliter (cfu/ml).
Rheological Studies in the Yogurt
The viscosity of yogurt was evaluated at the end of the
fermentation period using an AR2000ex Rheometer (TA
Instruments, Crawley, UK) fitted with a 60 mm diameter
aluminum parallel plate measurement system. The measuring
geometry had a gap size of 800 µm. All measurements were made
at 20◦C. Samples were initially stirred to achieve a homogenous
mixture. Samples were pre-sheared at 200 s−1 for 1 min, sheared
from 0.01 to 200 s−1 over 2 min, held at 200 s−1 for 1 min and
sheared from 200 to 0.01 s−1 over 2 min. The test was performed
in triplicate.
Water-Holding Capacity
The water-holding capacity (WHC) of the yogurt product was
measured according to the method of Sodini et al. (2005).
Before each analysis, yogurt samples were gently stirred to ensure
homogeneity. A sample of 20 g of yogurt (Y) was centrifuged
for 10 min at 1250 × g at 4◦C. The whey expelled (W) was
removed and weighed. The WHC (% w/w) was calculated as:
WHC = 100(Y−W)/Y. The measurement was carried out in
triplicate.
Chemical Analysis of Yogurt
The nitrogen content of yogurt was determined by the Kjeldahl
method (ISO, 2001). A nitrogen conversion factor of 6.38
was used for crude protein determination. Fat content was
determined by the Röse-Gottlieb method (IDF, 1996). Moisture
and total solids were determined by drying each yogurt sample
for 5 h in an oven at 105◦C (American Dairy Products Institute,
1990). Ash content was determined by drying at 550◦C according
to Horwitz (2000). Sugar content was calculated by difference
[total solids - (total protein+ fat+ ash)] as described by Guzman-
Gonzalez et al. (1999). All measurements were performed in
triplicate.
Statistical Analysis
The Student t-test was used to examine differences between
groups. Significance was set at p< 0.001.
RESULTS
Fish Screening
The strain isolated after plating serial dilutions of fish intestinal
content was screened for GABA production in liquid LM17 broth
supplemented with MSG. The strain produced over 50 µg/ml of
GABA.
This GABA-producing strain was then identified using
molecular techniques based on the sequencing of the 16S rRNA
gene previously amplified with PCR primers pA (AGAGTTT
GATCCTGGCTCAG) and pH’ (AAGGAGGTGATCCAGCC
GCA) (Edwards et al., 1989). Sequencing of the resulting
1.5 kb DNA fragment and comparison with the public databases
revealed a 99% identity to S. thermophilus strains. Hence, this
strain was named S. thermophilus APC151 and selected for
further studies.
GABA-Production in Culture Media and
Milk
In order to determine maximum rate of GABA production,
S. thermophilus APC151 was incubated for 72 h in LM17 broth
supplemented with 10 mg/ml MSG. The final concentration
measured in the supernatant was 2.1± 0.2 mg GABA/ml culture.
To test the ability of S. thermophilus APC151 to synthesize
GABA during milk fermentation, the strain was cultivated
in skim milk supplemented with 10 mg/ml MSG. Following
72 h incubation, a similar maximum concentration of GABA
(2.2 ± 0.2 mg/ml coagulated milk) was reached, thereby
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indicating that the switch from culture media to milk does not
alter GABA biosynthesis by S. thermophilus APC151. In order to
prevent accumulation of high levels of remaining MSG in yogurt,
a second test was performed in milk fermentations supplemented
with the minimum required concentration of MSG (2.25 mg/ml).
Maximum GABA accumulation (2.10 ± 0.16 mg/ml coagulated
milk) was in the same range indicating that 2.25 mg/ml was
the minimum concentration required to reach the maximum
GABA level in milk. Therefore, this concentration was selected
for subsequent yogurt trials.
Under similar conditions of study, strains S. thermophilus CH1
and Lb. bulgaricus CH1 isolated from the commercial yogurt
starter did not produce GABA.
Growth Dynamics of S. thermophilus
Strains during Yogurt Fermentation
The performance of the GABA-producer S. thermophilus
APC151 strain during milk fermentation was investigated during
fermentation of two different yogurts, the GABA yogurt (made
with strains S. thermophilus APC151 and Lb. bulgaricus CH1)
and the control yogurt (made with strains S. thermophilus CH1
and Lb. bulgaricus CH1). Species-specific bacterial counts were
monitored over 3 weeks (which included yogurt fermentation
and storage).
In both yogurt fermentations (GABA-enriched and control),
Lb. bulgaricus CH1 viable cell counts were identical, reaching 7.8
log unit after 6 h of fermentation and these numbers remained
constant until the end of the 1st week of storage. After this point
viable counts started to decrease to 5 log units by the end of the
3rd week.
The colony counts of both S. thermophilus strains increased
exponentially during the initial hours of fermentation to reach
a maximum of 9 log units (Figure 1A). This maximum
was reached in 4 h of fermentation by the APC151 strain
(µmax = 0.16 ± 0.01) and in 6 h of fermentation by the control
CH1 strain (µmax = 0.13 ± 0.01). Following the first 24 h,
the viability of the S. thermophilus strains started to decrease.
Noticeably, although this effect was observed in both strains
(APC151 and CH1), the reduction was more severe in the
industrially used CH1 strain (4.5 log units after 48 h and <1 log
units after day 7) than in the APC151 strain (7.5 log units after
48 h and 6.3 log units after day 7).
Interestingly, the performance of the two starters was
different in the two yogurts. In CH1 yogurt the S. thermophilus
outnumbered Lb. bulgaricus (9 versus 7.8 log units) over the first
24 h but this was reversed after the 2nd day. In contrast, the
S. thermophilus APC151 strain was the dominant species in the
GABA-enriched yogurt during the fermentation and storage and
remained viable (6.7 log units) after 3 weeks of storage at 4◦C.
Acidifying Kinetics of S. thermophilus
Strains during Milk Fermentation
The rate of milk acidification by S. thermophilus is a technological
trait of major importance for yogurt manufacture. Hence, the
pH curves of the control and GABA yogurts were recorded
during the fermentation process (2 days) and the initial 2 days
of storage. Interestingly, the acidification curves monitored in
both yogurts were very similar (Figure 1B). Although initial
pH decrease was slightly faster in the control yogurt, both
yogurts reached a pH value below 5.0 after 5 h, and by 8 h of
fermentation the pH was 4.4; thereby defining an acidification
rate (1pH/1t) of 0.33 ± 0.02 h−1 for the control CH1 yogurt
and 0.31 ± 0.02 h−1 for the GABA-enriched yogurt. The yogurt
pH at the end of the fermentation (48 h) was 3.8 and after
this time this value remained stable during storage at 4◦C for
3 weeks.
Since both S. thermophilus strains were able to ferment
milk individually (without co-culturing with Lb. bulgaricus), we
also characterized the pH curve of each strain in milk. Again,
pH curves were analogous for both strains CH1 and APC151
(Figure 1B). Compared to the co-culture with Lb. bulgaricus, the
pH decrease was less intensive, since pH 5.0 was reached after 6 h,
and by 8 h pH was 4.8 (1pH/1t = 0.22 ± 0.02 h−1). The milk
pH at the end of the fermentation (48 h) was 4.28 and after this
time this value remained stable during storage at 4◦C.
GABA Production during Yogurt
Fermentation
The presence of GABA in the control and GABA yogurts was
tested at different timepoints during yogurt fermentation and
storage (1, 1.5, 2, 3, 4, 5, 7, 14, and 21 days) (Figure 1C). There was
no production of GABA detected in the control yogurt. However,
in the GABA yogurt, accumulation of GABA started after the 1st
day and reached the maximum concentration (2.2 mg/ml) by the
end of the fermentation process (2 days). After this time, GABA
concentration remained constant until the end of the storage
period (3 weeks) at 4◦C.
Viscosity of the GABA Yogurt
The acidification that occurs during milk fermentation results in
milk coagulation due to destabilization of the micellar casein.
Thus, yogurt viscosity is an indication of gelation (Nouri
et al., 2011). The evolution of the viscosity was evaluated
in the GABA-containing and the control yogurts during the
initial 24 h of the fermentation. In both yogurts, the viscosity
started to increase gradually after 5 h of fermentation, just
when the pH decreased below 5.0, and a complete coagulation
occurred 2 h later, when the pH was 4.5 (Figure 2A). After
the 1st week of storage, the viscosity of the GABA yogurt
(0.34 ± 0.04 Pa-s) was significantly higher (p-value < 0.005)
than that of the control yogurt (0.23 ± 0.05 Pa-s) (Figure 2B).
After this time, viscosity of the control and GABA yogurts
increased gradually during storage for 2 (0.38 ± 0.04 and
0.40 ± 0.03 Pa-s, respectively) and 3 (0.49 ± 0.04 and
0.49 ± 0.01 Pa-s, respectively) weeks. Thus, at the end of the
storage period, the viscosity of both yogurts was not significantly
different.
Syneresis of the GABA Yogurt
Syneresis is known to have an important impact on quality and
acceptability of some fresh fermented products such as yogurt.
The water holding capacity (WHC) of the GABA-containing
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FIGURE 1 | Evolution of bacterial growth, pH and GABA accumulation in yogurt. (A) Growth of S. thermophilus (circles) and Lb. bulgaricus (squares) cell
count (cfu/ml) during fermentation and storage of the control (empty symbols) and GABA-enriched (filled symbols) yogurts. In the Y-axis the 0 value means
<10 cfu/ml (the detection limit). (B) Acidification curve of S. thermophilus APC151 (circles) and CH1 (squares) during milk fermentation in pure monoculture (empty
symbols) or co-cultures with Lb. bulgaricus CH1 (filled symbols). (C) Evolution of GABA accumulation in the GABA-enriched (white bars) and control (black bars)
yogurts over fermentation and storage time. Transition between fermentation and storage is indicated by the arrow [h, hours; d, days; w, weeks]. The representation
of time on X-axis is not to scale.
and the control yogurts was evaluated once a week during the
storage period. The WHC values obtained were 76.02 ± 1.05
and 82.71 ± 1.8% for the control and GABA-containing yogurts,
respectively (Figure 3). Hence, the latter has a slightly but
significantly lower (p-value < 0.005) susceptibility to syneresis
when compared to the control yogurt. After the 1st week, the
WHC of the GABA yogurt decreased gradually, whereas that of
the control yogurt held steady, thereby the WHC of both yogurts
was similar after the 2nd week of storage.
Chemical Composition
The GABA yogurt was evaluated for chemical properties using
the existing commercial CH1 yogurt as control. The results
(data not shown) demonstrate that the chemical composition
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FIGURE 2 | (A) Change in viscosity (solid line) and pH curve (dotted line) over milk fermentation during 24 h [Empty circles: control yogurt; Filled circles:
GABA-enriched yogurt]. (B) Evolution of viscosity over storage time for 1, 2, and 3 weeks [GABA-enriched (filled bars) and control (empty bars)]. ∗p-value < 0.001.
FIGURE 3 | Measurement of water holding capacity of GABA-enriched
(filled bars) and control (empty bars) yogurts after storage for 1, 2, and
3 weeks. ∗p-value < 0.001.
of the GABA-containing and reference yogurts was comparable
[moisture (87–88%), protein (5.05–5.65%), fat (0.12–0.15%),
sugar (4.8–5.8%), and ash content (0.74–1.2%)].
Yogurt composition did not vary over the storage period of
3 weeks. Thus, there was no significant difference in the chemical
composition of the GABA-enriched and control yogurts.
DISCUSSION
In this work, we isolated and identified a S. thermophilus
strain able to produce GABA during milk fermentation and
demonstrated its performance and suitability to be used as
a starter strain for yogurt manufacture. Prior to storage, the
fermentation was carried out for 48 h, the minimum time
required to reach maximum GABA production levels. Despite
the prolonged fermentation time, no adverse characteristics in the
yogurt were observed; viscosity and consistency increased and no
whey syneresis was observed. Regarding acidity, the final pH (4.3)
was in the range expected for yogurt (typically between 4 and 5)
(Lund et al., 2000).
The use of the S. thermophilus APC151 as a starter GABA
producer strain developed in this work would yield a yogurt
containing 2 mg/ml GABA. The ingestion of one unit of this
yogurt (100 g) would provide the consumer with 200 mg of
GABA. This concentration is above the bioactivity threshold
previously reported to result in blood-pressure-lowering and
antidiabetic effects on the consumer (Inoue et al., 2003; Pouliot-
Mathieu et al., 2013; Wan et al., 2015). Daily ingestion of 100 ml
of the GABA yogurt obtained in this study would supply a total
of 200 mg GABA, a dose equivalent to the GABA content of
a tablet (the daily recommended serving) of PharmaGABATM,
which is documented to have health benefits (Food and Drug
Administration [FDA], 2008).
Other fermented products enriched in GABA using GABA-
producing LAB as starters have been developed. These include
black raspberry juice (using Lb. brevis as source of GABA) (Kim
et al., 2009), kimchi (using Lactobacillus sp. as source of GABA)
(Seok et al., 2008), sourdough (Lb. plantarum and L. lactis as
source of GABA) (Rizzello et al., 2008), fermented soya milk
(Lb. brevis as source of GABA) (Park and Oh, 2007), and cheese
(L. lactis as source of GABA) (Nomura et al., 1998; Pouliot-
Mathieu et al., 2013). The development of GABA-containing
‘so-called’ yogurt has also been pursued using Lb. plantarum as
biological source of GABA (Shan et al., 2015). However, this
product cannot be called yogurt anymore in most countries
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due to legal issues (defined on a national law). The species
typically associated with the technological production of the
yogurt are S. thermophilus and L. delbrueckii subsp. bulgaricus
(Han et al., 2014). Recently, a S. thermophilus strain was utilized
to ferment and enrich milk in GABA (Chen et al., 2016).
However, the biotechnological attributes of this strain for yogurt
production were not studied and the fermentation was not
tested in co-culture with L. bulgaricus, as usually occurs in
yogurt manufacture. In this work, we isolated a S. thermophilus
strain technologically suitable for the production of a yogurt
containing 200 mg of GABA per serving without affecting its
microbiological, physical, and chemical properties. In this regard,
strain APC151 showed a milk acidity curve comparable to that
of a strain used as commercial starter for yogurt manufacture.
S. thermophilus strains in monoculture decreased milk pH to
4.2. A lower value (3.75) was reached when co-cultured with
the Lb. bulgaricus strain. This additional pH decrease is caused
by the Lb. bulgaricus strain, which is less susceptible to acid,
thereby gradually dominates the overall fermentation (Lourens-
Hattingh and Viljoen, 2001; Sfakianakis and Tzia, 2014), as we
observed in the control yogurt. However, in the GABA yogurt the
S. thermophilus strain remained viable throughout yogurt shelf
life, which could be due to a higher acid tolerance attributable
to its capability to decarboxylate glutamate and produce GABA
and ammonia. This fact could provide the strain an advantage to
survive the low pH conditions of the intestine. This ability is one
of the basic requirements for a microbe to produce GABA in the
intestine (Bravo et al., 2011).
During the 1st week of storage, the yogurt produced by the
GABA-producer strain had a higher viscosity thereby suggesting
a higher yogurt body, thickness, firmness, and consistency. This
could be due to the fact that the CH1 thermophilic starter culture
is intended to produce yogurt with strong flavor and low viscosity
(CH-1 Yo-Flex R© Specifications, Christian Hansen, Denmark).
Nevertheless, after this time viscosity of both yogurts was not
significantly different. A slight decrease of the WHC over the
storage period was observed in the two yogurts, which may be
correlated with higher syneresis. Long storage periods can cause
alteration of the yogurt microstructure, which ultimately leads
to syneresis (Mao et al., 2001; Aryana et al., 2006; Nguyen et al.,
2015).
In conclusion, S. thermophilus APC151 strain can ferment
milk and yield yogurt with equivalent microbial, rheological
and chemical properties to those observed in yogurt obtained
with a S. thermophilus strain typically used in industry. The
antibiotic resistance pattern of this strain was profiled and
atypical resistances were not found (data not shown). The
S. thermophilus strain proposed here provides GABA enrichment
in the yogurt, offering the possibility of production of new
naturally fermented GABA fortified yogurt with an added
value.
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